Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Corey Siegel, MD, MS
Dartmouth-Hitchcock Medical Center
Principal Investigator - Gil Melmed, MD, MS
Cedars-Sinai Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Inflammatory Bowel Disease Center
Los Angeles, California, United States
- Hoag Digestive Health
Newport Beach, California, United States
- Uc San Diego Health Inflammatory Bowel Disease Center
San Diego, California, United States
- University of Colorado Health
Denver, Colorado, United States
- Yale School of Medicine Ibd Program
New Haven, Connecticut, United States
- Medstar Georgetown University Hospital Center for Inflammatory Bowel Disease
Washington D.C., District of Columbia, United States
- Gastro Health Llc
Miami, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Atlanta Gastroenterology Associates
Atlanta, Georgia, United States
- Digestive Health Center
Boise, Idaho, United States
- University of Chicago Medicine Inflammatory Bowel Disease Center
Chicago, Illinois, United States
- Digestive Care Center
Evansville, Indiana, United States
- Gastrointestinal Specialists, A.M.C.
Shreveport, Louisiana, United States
- Corewell Health
Grand Rapids, Michigan, United States
- Dartmouth-Hitchcock Inflammatory Bowel Disease Center
Lebanon, New Hampshire, United States
- Saratoga Schenectady Gastroenterology Associates
Burnt Hills, New York, United States
- Nyu Long Island- Inflammatory Bowel Disease Center
Mineola, New York, United States
- New York University Langone Medical Center
New York, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- the Oregon Clinic - Gastroenterology
Portland, Oregon, United States
- Penn State Hershey Inflammatory Bowel Disease Center
Hershey, Pennsylvania, United States
- Regional Gi
Lancaster, Pennsylvania, United States
- Gastroenterology Associates
Providence, Rhode Island, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine Ibd Center
Houston, Texas, United States
- University of Utah Health Care
Salt Lake City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Feb 2016
- Primary completion
- 31 Dec 2030
- Completion
- 31 Dec 2030
- Last update posted
- 21 Aug 2025
- Registered enrollment
- 10,000
- Registry id
- NCT02791854
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.